Bal Pharma Q2 Results
- BSE: 524824
- NSE: BALPHARMA
- ISIN: INE083D01012
- Sector: Biotechnology & Drugs
BSE
133.2
-2.70 (-1.99%)
-2.70 (-1.99%)Volume631.00
Updated: Mon 25 Nov, 2024 | 15:15:00
NSE
134.4-2.75 (-2.01%)
-2.75 (-2.01%)Volume5.91 K
Updated: Mon 25 Nov, 2024 | 15:15:08
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹73.69 Cr.(-0.89%)
- Operating Profit₹5.22 Cr.(29.27%)
- Profit After Tax₹1.04 Cr.(302.12%)
- Operating Margin7.08%(24.17%)
Note: Comparison is on YoY basis
Quarterly - Bal Pharma Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 73.69 | 70.39 | -% | 92.54 | -% |
| Selling/ General/ Admin Expenses Total | 16.02 | 14.19 | -% | 15.30 | -% |
| Depreciation/ Amortization | 2.48 | 2.53 | -% | 2.42 | -% |
| Other Operating Expenses Total | 11.98 | 10.93 | -% | 16.23 | -% |
| Total Operating Expense | 68.47 | 66.48 | -% | 87.26 | -% |
| Operating Income | 5.22 | 3.91 | -% | 5.28 | -% |
| Net Income Before Taxes | 1.36 | 0.43 | -% | 1.60 | -% |
| Net Income | 1.04 | 0.08 | -% | 0.95 | -% |
| Diluted Normalized EPS | 0.65 | 0.06 | -% | 0.62 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST